Latest Production News

Otto Energy has secured a final Australian Taxation Office ruling clarifying the tax treatment of its recent $0.008 per share distribution, splitting it between a return of capital and a dividend.

BlackRock Investment Management has announced an estimated distribution of 176.55 cents per unit for its iShares MSCI South Korea ETF for the period ending June 30, 2025, predominantly sourced from foreign income.

ARC Funds Limited has completed a $750,000 equity raise through a placement and director share subscription, supporting its recent acquisitions and growth strategy.

Viridis Mining and Minerals is set to reveal key findings from its Pre-Feasibility Study on the Colossus Rare Earth Element Project, highlighting its global significance and strong economic potential.

Sports Entertainment Group (SEG) is set to become the sole broadcaster of all three Victorian racing codes after agreeing to acquire RSN’s brand and broadcasting assets for $3.25 million.

Australian Agricultural Projects Limited has completed its 2025 olive oil harvest, producing a record 752,600 litres with improved oil quality, despite weather challenges.

Manuka Resources Ltd has been reinstated to ASX trading following the announcement of a proposed material capital raising, signaling renewed investor interest.

Manuka Resources has launched a fully underwritten A$8 million entitlement offer to fund the restart of its Wonawinta processing plant and advance its 10-year Cobar Basin Production Plan, targeting silver and gold output by early 2026.

Orion Minerals has raised approximately A$5.8 million through a share placement and loan conversions, while launching a Share Purchase Plan targeting an additional A$4 million to fund key copper projects.

Hydralyte USA has placed 39.5 million shortfall shares at $0.01 each, boosting total funds raised under its recent Rights Issue to nearly $559,000. The move strengthens the company’s capital position amid ongoing growth efforts.

L1 Capital and Platinum Asset Management have formalised their merger with a binding agreement, promising continuity for L1 Long Short Fund's management and strategy.

Nova Eye Medical has reported a record A$28.8 million in revenues for FY25, driven by strong US sales and sustained growth of its flagship iTrack™ Advance device.